Home >> Signaling Pathways >> Apoptosis

Apoptosis(凋亡)

As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.

Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.

Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.

Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.

Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.

Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.

One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.

p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.

Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9). 

Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.

References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.

Products for  Apoptosis

  1. Cat.No. 产品名称 Information
  2. GC48436 4'-Acetylchrysomycin B A bacterial metabolite with antibacterial and anticancer activities
  3. GC48434 Elsinochrome A

    痂囊腔菌素AELSINOCHROMEA

    A fungal metabolite
  4. GC48433 BX-320

    N1-[3-[[5-溴-2-[[3-[(1-吡咯烷基羰基)氨基]苯基]氨基]-4-嘧啶基]氨基]丙基]-2,2-二甲基丙烷二酰胺

    An inhibitor of PDK1
  5. GC48430 Ac-DEVD-CMK (trifluoroacetate salt)

    AcAspGluValAspCMK, Caspase3 Inhibitor III

    An inhibitor of caspase-3
  6. GC48423 19-O-Acetylchaetoglobosin A

    Chaetoglobosin A Acetate

    A fungal metabolite with actin polymerization inhibitory and cytotoxic activities
  7. GC48418 N-(2-Poc-ethyl)betulin amide An alkyne derivative of betulin
  8. GC48409 Burnettramic Acid A aglycone A fungal metabolite with anticancer activity
  9. GC48406 PSI (trifluoroacetate salt)

    Proteasome Inhibitor I, Z-Ile-Glu(OtBu)-Ala-Leu-aldehyde, Z-Ile-Glu(OtBu)-Ala-Leu-CHO

    A proteasome inhibitor
  10. GC48401 Risuteganib (trifluoroacetate salt)

    ALG-1001

    An anti-integrin peptide
  11. GC48399 MTP 131 (acetate)

    Elamipretide, SS-31

    A mitochondria-targeted peptide antioxidant
  12. GC48392 CAY10747 An inhibitor of the Hsp90-Cdc37 protein-protein interaction
  13. GC48387 Inostamycin A A bacterial metabolite with anticancer activity
  14. GC48376 Burnettramic Acid A A fungal metabolite with diverse biological activities
  15. GC48374 Saikosaponin D (hydrate) A triterpene saponin with diverse biological activities
  16. GC48356 Psychotridine An alkaloid with diverse biological activities
  17. GC48354 Stephacidin B

    (-)-Stephacidin B

    A fungal metabolite
  18. GC48350 Amycolatopsin C A polyketide macrolide with antimycobacterial and anticancer activities
  19. GC48341 Amycolatopsin B A bacterial metabolite
  20. GC48339 Amycolatopsin A A macrolide polyketide with antimycobacterial and anticancer activities
  21. GC48335 N-glycolyl-Ganglioside GM3 Mixture (ammonium salt)

    GM3-Neugc, NeuGc-GM3, NGcGM3, N-glycolyl-GM3, N-glycolyl-Monosialoganglioside GM3, N-Glycolylneuraminyllactosylceramide

    A mixture of N-glycolyl-ganglioside GM3
  22. GC48292 α-MSH (human, mouse, rat, porcine, bovine, ovine) (trifluoroacetate salt)

    Α-促黑激素,α-Melanocyte-Stimulating Hormone TFA

    A peptide hormone
  23. GC48261 XTT (sodium salt hydrate) A cell-impermeable, negatively charged tetrazolium dye
  24. GC48258 Xanthoquinodin A1

    Xanthoquinidone C

    A fungal metabolite with diverse biological activities
  25. GC48247 Verrucarin A

    疣孢菌素,Muconomycin A

    A macrocyclic trichothecene with diverse biological activities
  26. GC48230 Ursodeoxycholic Acid-d4

    3β-熊去氧胆酸 d4

    An internal standard for the quantification of ursodeoxycholic acid
  27. GC48210 TRX-818 (sodium salt) An anticancer compound
  28. GC48202 Treprostinil (diethanolamine salt)

    曲前列尼尔二乙醇胺盐,UT-15C

    An agonist of IP2, DP2, and EP2 receptors
  29. GC48195 trans-trismethoxy Resveratrol-d4

    (E)-5-2-(4-hydroxyphenyl)ethenyl-1,3-benzene diol-d4, TMS-d4, trans-3,5,4'-Trimethoxystilbene-d4

    An internal standard for the quantification of trans-trismethoxy resveratrol
  30. GC48165 Thiocoraline

    PM 93135

    A depsipeptide and DNA bis-intercalator with antibacterial and anticancer activities
  31. GC48135 Tebufenozide

    虫酰肼

    An insecticide and ecdysone receptor agonist
  32. GC48124 Tamoxifen-d5

    ICI 47699-?d5; (Z)-Tamoxifen-?d5; trans-Tamoxifen-?d5

    An internal standard for the quantification of tamoxifen
  33. GC48119 Suprafenacine

    SML1493

    An inhibitor of tubulin polymerization with anticancer activity
  34. GC48118 Sunitinib-d10

    舒尼替尼-D10,SU 11248-d10

    An internal standard for the quantification of sunitinib
  35. GC48099 SR 12460 An IKKβ NBD mimetic
  36. GC48098 SR 12343 An IKKβ NBD mimetic
  37. GC48096 Sporogen-AO 1

    (+)-Sporogen-AO 1

    A fungal metabolite with diverse biological activities
  38. GC48084 Sodium 4-Phenylbutyrate-d11

    4-PBA-d11 sodium; 4-Phenylbutyric acid-d11 sodium; Benzenebutyric acid-d11 sodium

    An internal standard for the quantification of sodium 4-phenylbutyrate
  39. GC48076 Sesquicillin A

    Sesquicillin

    A fungal metabolite
  40. GC48028 Rasagiline-13C3 (mesylate)

    甲磺酸雷沙吉兰-13C3

    An internal standard for the quantification of rasagiline
  41. GC48027 Rapamycin-d3

    三氘代雷帕霉素,Sirolimus-d3; AY-22989-d3

    An internal standard for the quantification of rapamycin
  42. GC48022 Radotinib-d6

    IY-5511

    Radotinib-d6 是氘标记的 Radotinib。
  43. GC48020 Quercetin-d3 (hydrate) A neuropeptide with diverse biological activities
  44. GC48019 Quercetin (hydrate)

    槲皮素二水合物

    A flavonoid with diverse biological activities
  45. GC47972 Previridicatumtoxin A fungal metabolite with diverse biological activities
  46. GC47955 Phloroglucinol

    间苯三酚

    A phenol with diverse biological activities
  47. GC47923 Paraxanthine-d6

    1,7-Dimethylxanthine-d6

    An internal standard for the quantification of paraxanthine
  48. GC47853 Paclitaxel-d5

    紫杉醇 d5

    An internal standard for the quantification of paclitaxel
  49. GC47818 Oleic Acid-d17

    cis-9-Octadecenoic Acid-d17

    An internal standard for the quantification of oleic acid
  50. GC47805 N-Phenylthiourea

    苯基硫脲

    A tyrosinase inhibitor and building block
  51. GC47803 Noscapine-13C-d3

    Narcotine-13C-d3, Opianine-13C-d3

    An internal standard for the quantification of noscapine

Items 851 to 900 of 2733 total

per page

Set Descending Direction